Differential Anti-Adipogenic Effects of Eicosapentaenoic and Docosahexaenoic Acids in Obesity

Mol Nutr Food Res. 2019 Jul;63(14):e1801135. doi: 10.1002/mnfr.201801135. Epub 2019 Jun 12.

Abstract

Scope: To assess the associations of plasma eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with body fat in a population-based sample and explore the mechanism of action based on browning of white adipose tissue (WAT) in high-fat-diet-induced obese (DIO) mice and 3T3-L1 adipocytes.

Methods and results: Plasma EPA and DHA of 1719 adults in the National Health and Nutrition Examination Survey (2003-2004) are determined by gas chromatography mass spectrometry, while total body fat is measured by dual-energy X-ray absorptiometry. DIO mice are fed a high-fat diet supplemented with EPA or DHA (1% wt/wt) for 15 weeks and 3T3-L1 preadipocytes are treated with EPA or DHA during differentiation. Plasma DHA but not EPA is associated with lower body fat mass (ptrend < 0.0001), which persists in overweight/obese subjects (ptrend = 0.02). DHA supplementation reduces inguinal WAT and exhibits a more pronounced thermogenic effect than EPA in DIO mice. In vitro, the browning process is induced after 2-day and 6-day treatment with DHA and EPA, respectively.

Conclusion: Plasma DHA but not EPA is inversely associated with body fat mass. The more potent anti-adipogenic effect of DHA than EPA may involve a better capability of inducing browning of WAT for DHA.

Keywords: adiposity; browning of white adipose; docosahexaenoic acid; eicosapentaenoic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipogenesis / drug effects
  • Adipogenesis / physiology*
  • Adipose Tissue, White / drug effects
  • Adipose Tissue, White / physiology
  • Animals
  • Anti-Obesity Agents / pharmacology
  • Body Fat Distribution
  • Diet, High-Fat / adverse effects
  • Dietary Supplements
  • Docosahexaenoic Acids / blood*
  • Docosahexaenoic Acids / pharmacology
  • Eicosapentaenoic Acid / blood*
  • Eicosapentaenoic Acid / pharmacology
  • Female
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Middle Aged
  • Nutrition Surveys
  • Obesity / blood*
  • Obesity / etiology
  • United States

Substances

  • Anti-Obesity Agents
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid